# Evolocumab In Advanced Chronic Kidney Disease Trial

> **NCT04510844** · PHASE4 · WITHDRAWN · sponsor: **NYU Langone Health**

## Conditions studied

- Chronic Kidney Diseases
- High Cholesterol

## Interventions

- **DRUG:** Evolocumab
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04510844
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03-01
- **Primary completion:** 2021-10-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** loss of funding
- **Last updated:** 2022-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04510844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04510844, "Evolocumab In Advanced Chronic Kidney Disease Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04510844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*